Besser James E Insider Trades

Insider Trading History

Track insider trading activity for Besser James E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Modular Medical
Modular Medical MODD
10% owner, Chief Executive Officer
Holding Value $634k 135,136 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 135,136 shares
$1.11
$4.69
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Holding Value $1.82M 648,300 shares
Last Trade
Apr 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.03B 400,000 shares
$5,075.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Holding Value $1.82M 648,300 shares
Last Trade
Apr 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.03B 400,000 shares
$5,075.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Holding Value $2.94M 1,048,300 shares
Last Trade
Apr 07, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$83.7M 16,000 shares
$5,230.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Holding Value $2.94M 1,048,300 shares
Last Trade
Apr 07, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$83.7M 16,000 shares
$5,230.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Holding Value $2.98M 1,064,300 shares
Last Trade
Apr 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$171M 31,771 shares
$5,375.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Holding Value $2.98M 1,064,300 shares
Last Trade
Apr 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$171M 31,771 shares
$5,375.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $3.07M 1,096,071 shares
Last Trade
Feb 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$122M 20,929 shares
$5,815.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $3.07M 1,096,071 shares
Last Trade
Feb 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$122M 20,929 shares
$5,815.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $3.13M 1,117,000 shares
Last Trade
Feb 19, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.3M 3,000 shares
$5,445.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $3.13M 1,117,000 shares
Last Trade
Feb 19, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.3M 3,000 shares
$5,445.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $3.14M 1,120,000 shares
Last Trade
Feb 18, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.3M 5,000 shares
$5,250.00
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $3.14M 1,120,000 shares
Last Trade
Feb 18, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.3M 5,000 shares
$5,250.00
$2.80
NeuroOne Medical Technologies
NeuroOne Medical Technologies NMTC
10% owner
Holding Value $0 0 shares
Last Trade
Jan 15, 2021 Sale
$7.55M 4,750,000 shares
$1.59
$3.47
NeuroOne Medical Technologies
NeuroOne Medical Technologies NMTC
10% owner
Holding Value $0 0 shares
Last Trade
Jan 15, 2021 Sale
$398k 250,000 shares
$1.59
$3.47
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
10% owner
Holding Value $1.13M 405,000 shares
Last Trade
Oct 02, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$59.3M 30,000 shares
$1,975.00
$2.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up